ICAP
PTLA

Independence Capital Asset Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Independence Capital Asset Partners’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-100,025
Closed -$2.46M – 123
2013
Q2 		$2.46M Buy
+100,025
New +$1.99M 0.43% 58

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Independence Capital Asset Partners's PTLA Position: Q3 2013 in Review

Independence Capital Asset Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2013, closing a stake of 100,025 shares — an estimated $2.46M sold.

Independence Capital Asset Partners first reported a position in PTLA in Q2 2013 and held it in 1 quarter. The position peaked at $2.46M in Q2 2013. 69 funds tracked by Wall St. Rank hold PTLA as of Q3 2013.

  • Independence Capital Asset Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • Independence Capital Asset Partners sold 100,025 Portola Pharmaceuticals, Inc. shares in Q3 2013, an estimated $2.46M.
  • Independence Capital Asset Partners first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • Independence Capital Asset Partners's Portola Pharmaceuticals, Inc. position peaked at $2.46M in Q2 2013.
  • 69 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2013.

Based on Independence Capital Asset Partners's 13F filing for Q3 2013, filed 14 Nov 2013.